Related Experiment Video

Updated: May 26, 2026

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

Influence of access site selection on PCI-related adverse events in patients with STEMI: meta-analysis of randomised

Mamas A Mamas1, Karim Ratib, Helen Routledge

  • 1Clinical Lecturer in Cardiology, Manchester Heart Centre, Manchester Royal Infirmary, Manchester M13 9PT, UK. mamasmamas1@yahoo.co.uk

Heart (British Cardiac Society)
|December 8, 2011
PubMed

Insights

Transradial percutaneous coronary intervention (PCI) significantly reduces mortality, major adverse cardiac events (MACE), and access site complications in ST-elevation myocardial infarction (STEMI) patients compared to the transfemoral approach. This meta-analysis supports radial access as the preferred method for STEMI PCI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • ST-elevation myocardial infarction (STEMI) is a critical condition requiring timely reperfusion therapy.
  • Percutaneous coronary intervention (PCI) is a primary treatment strategy for STEMI.
  • Vascular access route (transradial vs. transfemoral) can influence procedural outcomes and patient safety.

Purpose of the Study:

  • To conduct a meta-analysis of randomized controlled trials comparing transradial and transfemoral access for PCI in STEMI patients.
  • To define optimal practice by evaluating key clinical outcomes associated with each access route.

Main Methods:

  • A systematic literature search was performed using Medline and Embase databases.
  • Included randomized controlled studies comparing transradial versus transfemoral PCI in STEMI patients.
  • Analyzed data from 9 studies involving 2977 patients, focusing on mortality, MACE, major bleeding, and access site complications.

Main Results:

  • Transradial PCI was associated with significantly lower mortality (OR 0.53) and MACE (OR 0.62) compared to transfemoral PCI.
  • A significant reduction in access site complications was observed with the transradial approach (OR 0.30).
  • While major bleeding showed a trend towards reduction, it did not reach statistical significance (OR 0.63).

Conclusions:

  • Transradial access in STEMI PCI leads to significant reductions in mortality, MACE, and major access site complications.
  • The findings support the preferential use of the transradial route for PCI in patients with STEMI.
  • This approach enhances patient safety and procedural success in acute myocardial infarction management.
Abstract

More Related Videos

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...